PQ 354
354. Deputy Alan Kelly asked the Minister for Health the way in which the gainshare and incentive model for biosimilar prescribing operates; if €500 per patient is being allocated to hospital treatment areas that prescribe biosimilars is taking place as reported; if the HSE or his Department has estimated the overall savings potential of biosimilar prescribing; and if he will make a statement on the matter. [52711/19]
Introduced
17 December 2019
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
17 December 2019
Summary
354. Deputy Alan Kelly asked the Minister for Health the way in which the gainshare and incentive model for biosimilar prescribing operates; if €500 per patient is being allocated to hospital treatment areas that prescribe biosimilars is taking place as reported; if the HSE or his Department has estimated the overall savings potential of biosimilar prescribing; and if he will make a statement on the matter. [52711/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products
Medicinal Products
xml · EN · 17 December 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-12-17/354/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-12-17/pq_354